A 53-year-old man underwent esophagogastroduodenoscopy showing chronic gastritis with *Helicobacter pylori* (HP) infection. The first-line therapy for HP eradication failed, and the patient underwent second-line therapy comprising amoxicillin, metronidazole and vonoplazan. Three days after completing the treatment, he developed abdominal pain and hematochezia. Computed tomography showed thickening of the ascending colonic wall ([Picture 1](#g001){ref-type="fig"}). Colonoscopy showed hemorrhagic and edematous mucosa in the ascending colon ([Picture 2](#g002){ref-type="fig"}). A biopsy of the mucosa and stool culture provided no specific findings. The patient was diagnosed with antibiotic-associated hemorrhagic colitis (AAHC). He had a bowel rest and recovered. AAHC is a well-known complication of taking antibiotics and usually affects the ascending and transverse colon. Although several reports have suggested that antibiotic-induced overgrowth of *Klebsiella oxytoca* or allergic reaction can be associated with the development of AAHC, the definitive cause remains unknown ([@B1]). In Japan, the incidence rate of AAHC induced by first-line eradication therapy is reportedly 0.35-0.6% while the incidence rate with second-line eradication therapy is reportedly 0.96% ([@B2]). Clinicians should be aware of the possibility of AAHC after second-line therapy, even when no adverse events develop after first-line therapy.
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